Cabaletta Bio, Inc.
CABA
$3.04
$0.124.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.07% | -28.64% | -46.48% | -63.50% | -43.50% |
| Total Depreciation and Amortization | -30.52% | -25.64% | -18.63% | 9.86% | 23.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.66% | 28.06% | 40.28% | 58.44% | 60.61% |
| Change in Net Operating Assets | -207.55% | -156.09% | -92.58% | 13,212.90% | 26.22% |
| Cash from Operations | -38.18% | -52.85% | -69.80% | -46.36% | -28.41% |
| Capital Expenditure | -- | 45.48% | 69.17% | 79.09% | 3.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 300.00% | -500.02% | -300.14% | -- |
| Cash from Investing | 6,591.72% | 310.71% | -508.92% | -307.32% | 3.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -673.73% | -113.15% | -- | -- | -- |
| Issuance of Common Stock | -- | 94.42% | -- | 25,328.76% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,677.36% | 90.58% | -1,235.21% | 24,536.68% | -108.05% |
| Foreign Exchange rate Adjustments | -285.71% | 60.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 204.73% | 442.70% | -966.91% | 315.12% | -79.06% |